GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Shanghai Rongtai Health Technology Corp Ltd (SHSE:603579) » Definitions » 5-Year EBITDA Growth Rate

Shanghai Rongtai Health Technology (SHSE:603579) 5-Year EBITDA Growth Rate : -4.50% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shanghai Rongtai Health Technology 5-Year EBITDA Growth Rate?

Shanghai Rongtai Health Technology's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.18.

During the past 12 months, Shanghai Rongtai Health Technology's average EBITDA Per Share Growth Rate was -9.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 7.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -4.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shanghai Rongtai Health Technology was 107.90% per year. The lowest was -11.20% per year. And the median was 7.70% per year.


Competitive Comparison of Shanghai Rongtai Health Technology's 5-Year EBITDA Growth Rate

For the Leisure subindustry, Shanghai Rongtai Health Technology's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Rongtai Health Technology's 5-Year EBITDA Growth Rate Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Rongtai Health Technology's 5-Year EBITDA Growth Rate falls into.


;

Shanghai Rongtai Health Technology 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Shanghai Rongtai Health Technology  (SHSE:603579) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Shanghai Rongtai Health Technology 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Rongtai Health Technology's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Rongtai Health Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 1226 ZhuFeng Road, Qingpu District, Shanghai, CHN, 201702
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
Executives
Cao Tao Supervisors
Ying Jian Sen Director
Lin Guang Sheng Director
Lin Qi Director

Shanghai Rongtai Health Technology Headlines

No Headlines